Results 211 to 218 of about 75,323 (218)

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

Cancer Treatment Reviews, 2013
Anne Polk
exaly  

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Lancet Oncology, The, 2014
Sung Hoon Noh, Sook Ryun Park, Han-Kwang Yang   +2 more
exaly  

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

Lancet Oncology, The, 2013
David Cunningham
exaly  

Brain metastases respond to neratinib plus capecitabine

Nature Reviews Clinical Oncology, 2019
exaly  

Capecitabine

Reactions Weekly
  +4 more sources

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Annals of Oncology, 2009
exaly  

Leopard-like vitiligo with capecitabine

Lancet, The, 2001
exaly  

Capecitabin

2013
openaire   +1 more source